MedznMore, Pakistan’s most successful health-tech startup, has made the difficult decision to halt its operations in response to the deteriorating macroeconomic situation in the country. The company officially announced the cessation of its operations in early June, citing the unfavorable economic conditions as a significant factor in this decision.
Co-founder Saad Khawar expressed his concerns about the declining macroeconomic indicators in Pakistan, stating, “The worsening economic conditions in Pakistan over the past several months have coincided with our fundraising efforts, making it an especially challenging time for us.” In a statement, Khawar also revealed that the management is currently engaged in discussions with potential buyers who are interested in acquiring MedznMore’s technology and brand, Tabiyat.pk. He assured stakeholders that there is no significant asset-liability gap, and the company is diligently working to settle any remaining liabilities.
Despite the outcome not meeting their expectations, Khawar expressed immense pride in the accomplishments of MedznMore, highlighting the remarkable team that helped build the company. “I am sincerely grateful to all of my amazing colleagues for their invaluable contributions. Although our journey did not unfold as we had envisioned, I take great pride in what we were able to achieve together,” he said.
MedznMore was founded in September 2020 and quickly garnered attention by securing $2.6 million in seed capital in October of the same year, marking the largest funding round in Pakistan’s history at that time. In May 2022, the company announced its next round of funding, amounting to $11.5 million. This funding round saw participation from both local and foreign investors, including Integra Partners, Nunc Gestion, Atlas Group, Sturgeon Capital, Alta Semper, Lakson Group, and Premier Group.
During its operation in the local health-tech sector, MedznMore made a significant impact by providing B2B healthcare services to over 10,000 pharmacies. The company also developed Tabiyat.pk, an online pharmacy catering to the B2C market.
While the decision to cease operations is undoubtedly disappointing for MedznMore and its stakeholders, the company remains optimistic about the potential sale of its technology and brand, which could pave the way for future developments in the Pakistani health-tech industry.